Conventional Dosing vs alternate day dosing of Follicle Stimulating Hormone (FSH) in IVF/ICSI

Not Applicable

• Conditions: Health Condition 1: O090- Supervision of pregnancy with history of infertility

• Registration Number: CTRI/2023/03/050903
• Lead Sponsor: Indira IVF Hopsital Private Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

(a) All-female patients undergoing IVF with own oocyte

(b) Age -25- 40 years

(c) BMI- 18.5 -25.5

(d) AMH- 1.5-4.5 ng/dl

Exclusion Criteria

(a) PCOD

(b) Endometriosis

(c) Uncontrolled Diabetes

(d) Uncontrolled thyroid abnormalities

(e) Uncontrolled hyperprolactinemia

(f) Heart disease

(g) Known case of autoimmune disease

(h) Male partner with severe male factor infertility less than 5 million per ml

(i) Those who will require surgically retrieved sperm for ICSI.

(j) Subjects who are intrauterine device (IUD) carriers in the last three months before embryo transfer

(k) Adenomyosis diagnosed by Ultrasonography.

Any pathological finding affecting the endometrial cavity

(l) Illness or unstable medical condition may put at risk the patient safety and her compliance in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
M2 rateTimepoint: At the time of pick up

Secondary Outcome Measures

Name	Time	Method
Blast RateTimepoint: Day 5 after OPU;Clinical Pregnancy RateTimepoint: 4 weeks following ET;Follicle Oocyte IndexTimepoint: On day of OPU;Good Blast RateTimepoint: Day 5 after OPU;Implantation RateTimepoint: 4 weeks following ET;OHSS RateTimepoint: 3 weeks after OPU;Retrieval RateTimepoint: At the time of pick up;Total FSH usedTimepoint: Day of Trigger